baber/WOPTO huggingface dataset:
Patent DE-69926055-T2 (DE)
Inventor: ZILLA PAUL
IPC: B29C48/09
Filed: 1999-11-19
Granted: 2006-05-18
Abstract: A vascular prosthesis is constructed from a structure having interconnected, helically oriented channel porosity to allow oriented ingrowth of connective tissue into a wall of the prosthesis. The prosthesis can have a small internal diameter of 6 mm or less. Several different method can be used to produce the prosthesis, including a fiber winding and extraction technique, a melt extrusion technique, and a particle and fiber extraction technique using either a layered method or a continuous method. Furthermore, mechanical properties of the prosthesis are matched with mechanical properties of the host vessel, thereby overcoming problems of compliance mismatch.
Patent DE-69929443-T2 (DE)
Inventor: KAPIKIAN Z
IPC: A61K39/15
Filed: 1999-07-27
Granted: 2006-07-27
Abstract: The present invention provides vaccine compositions for protection against human rotaviral disease without significant reactogenicity. Human×bovine reassortant rotavirus comprising each of the four clinically most important VP7 serotypes of human rotavirus are combined in a multivalent formulation which provides a high degree of infectivity and immunogenicity without producing a transient febrile condition. Methods for producing an immunogenic response without producing a transient febrile condition are also provided.
Patent HU-E032695-T2 (HU)
Title: Tapentadol for treating rheumatoid arthritic pain
Inventor: JAHNEL ULRICH
IPC: A61P25/04
Filed: 2010-04-26
Abstract: The use of 1-phenyl-3-dimethylaminopropane compounds for the treatment of rheumatoid pain, especially rheumatoid arthritic pain, very especially preferably chronic rheumatoid arthritic pain.
Patent TR-200001025-T2 (TR)
Title: Polimerik liflerin özelliklerini ölçmek için teknik
Inventor: WIJK ROBERT JAN VAN
IPC: G01N21/89
Filed: 1998-08-24
Abstract: Bulus polimerik liflerin boya emisini belirlemek veya bir daha fazla yapisal parametresini veya mekanik özelligi ölçmek için bir teknige iliskindir. Bu teknik bir egirme islemi sirasinda veya sonrasinda Raman spektrumunun ölçülmesine dayanir. Raman spektrumu islemden geçirildikten sonra, incelenecek liflerle ayni kimyasal bilesime sahip liflerin Raman spektrumlarindan elde edilen bir model uygulanir.
Patent TR-200002119-T2 (TR)
Title: Veri tabanı cihazı.
Inventor: SHADMON MOSHE
IPC: G06F12/00
Filed: 1999-01-22
Abstract: Veri kayitlarinin bloklar halinde düzenlenmis ve bir saklama biriminde yer alan bir tray indeksine bagli oldugu, veri islem sisteminde uygulanan ve veri kayitlarina erisim için bir veritabani dosya idare sistemi. Tray indeksi, veri kayitlarinin anahtar  erisimine veya güncellenmesine izin verir ve dengesiz blok yapisina duyarlidir. Tray indeksinin sunulmasi ve bunun temsili anahtarlari üzerinde temsili bir indeksin olusturulmasi asamalarini kapsayan, bloklar halinde düzenlenmis bir tabakali indeks yapimi için bir metot verilmistir.
Patent TR-200102566-T2 (TR)
Title: Kontrollü salınan betahistin bileşimleri.
Inventor: FABIO FLAVIO
IPC: A61K9/26
Filed: 2000-02-28
Abstract: Oral, kati, kontröllü olarak salinan betahistin bilesimleri, aktif tertip maddesinin yagli bir bilesikle eriterek granülasyon islemine maruz birakilmasiyla ve daha sonra elde edilen granülatin, hidrofilik bir polimerle ve geleneksel eksipiyanlarla karistirilmasiyla elde edilir.
Patent TR-200102946-T2 (TR)
Inventor: ROSSI FRANCESCO
IPC: C04B26/26
Filed: 2000-04-12
Abstract: A fibrous reinforcing material (1) is envisaged which is produced from glass filaments (2), advantageously consisting of fragments of glass yarns (3) or of chopped yarns, having a mean diameter of greater than five micrometers and a mean length of greater than six millimeters. The process comprises a selection step (4a, 4b) during which the glass yarns (3) consisting of filaments having a diameter greater than or equal to five micrometers and less than or equal to twenty-four micrometers are chosen, optionally a step (5) of mixing the selected yarns, and a milling step (6) during which the mixed yarns are chopped into filaments (2) having a length of greater than or equal to six millimeters. Advantageously, the fibrous material is in the form of flakes.
Patent TR-200201364-T2 (TR)
Inventor: ADAMS JERRY L
IPC: A61P9/10
Filed: 2000-11-20
Abstract: The present invention is directed to novel compounds of Formula (I) for use in the treatment of diseases, in a mammal, in which inappropriate, excessive or undesirable angiogenesis has occurred and/or where excessive Tie2 receptor activity has occurred.
Patent DE-602004000016-T2 (DE)
Inventor: DE HAAN PIETER
IPC: A61K9/20
Filed: 2004-05-19
Granted: 2005-11-03
Abstract: An immediate-release pharmaceutical dosage form comprising, as the active substance, polymorphous tibolone and pharmaceutically acceptable excipients, wherein the polymorphous tibolone has a mean particle size as defined in the specification of below 22.8 mum in the dosage form.
Patent DE-602004001855-T2 (DE)
Inventor: SALICE LUCIANO
IPC: E05B17/00
Filed: 2004-10-14
Granted: 2007-11-29
Abstract: Latch device composed of a container ( 51 ) in which there is a slider ( 52 ), inserted in a guide ( 60 ), controlled in translation by a spring ( 53 ) and comprising a hook ( 68 ) to catch a hooking element ( 59 ) placed on a door. A track ( 40 ), with the bottom defining the profile of a cam on one side of the guide ( 60 ), is travelled along by a ball ( 73 ) placed on the slider ( 52 ) and held pressed by a spring ( 72 ) against the bottom of the track ( 40 ) to determine the four open, closed, released and locked positions of the door according to the position of the ball in the track.
Patent DE-602004003737-T2 (DE)
Inventor: HEENEY MARTIN
IPC: C07C17/26
Filed: 2004-03-18
Granted: 2007-10-04
Abstract: The invention relates to a process of preparing disubstituted 9-alkylidenefluorenes and structure analoguous compounds, to novel compounds and intermediates prepared by this process, their use for the preparation of conjugated polymers and copolymers thereof, and to novel polymers and copolymers thereby prepared.
Patent DE-602004009606-T2 (DE)
Inventor: FAVEREAU DANIEL A
IPC: B32B15/00
Filed: 2004-12-08
Granted: 2008-07-24
Abstract: Articles made from blends of hydrofluorocarbon polymer such as copolymer of ethylene and tetrafluoroethylene, with boron nitride show improved scrape abrasion resistance.
Patent DE-602005003817-T2 (DE)
Inventor: FOURNIE-ZALUSKI MARIE-CLAUDE
IPC: C12Q1/00
Filed: 2005-05-04
Granted: 2008-12-04
Abstract: A peptide substrate selectively recognisable by a botulinum toxin A, BoNT/A containing a Nop-(Z)-Pya fragment in the peptide structure thereof, wherein Z is an aminoacid chain, preferably RA and the fragment is cleaved by the toxin.
Patent DE-602005005857-T2 (DE)
Inventor: MENTINK LEON
IPC: C08K5/101
Filed: 2005-12-20
Granted: 2009-04-09
Abstract: Use of a compound (A) (esters of an organic acid other than fatty acid, where the acid comprises 10C (preferably 2-8C) and ethers/esters of a product resulting from internal dehydration of a sugar (preferably a hydrogenated sugar) for preparing/treating composition (I) comprises bitumen, hydrocarbon and/or resin. Independent claims are also included for: (1) a process of preparing/treating (I); and (2) (I).
Patent DE-3855220-T3 (DE)
Inventor: JUDY MILLARD
IPC: A61L2/08
Filed: 1988-06-24
Granted: 2001-11-08
Abstract: A method for externally eradicating infectious pathogenic contaminants, such as enveloped viruses, bacteria, trypanosomal and malarial parasites, present in body tissues, such as blood, blood components, semen, skin, and cornea, before the treated body tissues are introduced into, or transplanted onto, the body of a human or an animal. Such method includes the steps of: (1) admixing an effective, non-toxic amount of photoactive compound, which has a selectively for binding to the infectious pathogenic biological contaminants present therein, with the body tissues outside the body to produce resulting body tissues; (2) maintaining the resulting body tissues in a suitable container in which there is no net mass transfer, and (3) irradiating the resulting body tissues in the container for an effective period of time with an effective level of radiation such that the radiation penetrates the resulting body tissues and eradicates the photoactive-compound-bound contaminants present in the resulting body tissues and produces a decontaminated body tissue suitable for introducing into, or transplanting onto, the body of a human or animal.
Patent DE-60029981-T3 (DE)
Inventor: NESTENBORG DANIEL
IPC: A61F5/451
Filed: 2000-09-28
Granted: 2012-01-05
Abstract: A rectal insertion device ( 1 ) for the treatment of disorders of the digestive tract of a human or animal patient having a body ( 3, 5 ) comprises a forward section ( 8 ) which in an operative position of the device is disposed in the anal canal of the patient, a first passageway ( 9 ) which extends forward opening ( 11 ) in the forward section, a rearward section ( 3 ) having a forward end which in the operative position is disposed extra-coporeally and a second passageway ( 4 ) which extends rearwardly in the device from a second forward opening ( 7 ) in the forward end of the rearward section. The second passageway acts to catch faeces discharged from the anal canal not caught in the first passageway.
Patent DE-69636937-T3 (DE)
Inventor: MITCHELL LLOYD G
IPC: C07K14/34
Filed: 1996-12-13
Granted: 2011-01-05
Abstract: The molecules and methods of the present invention provide a means for in vivo production of a therapeutic molecule in a selected subset of cells. The pre-therapeutic molecules of the invention are substrates for a trans-splicing reaction between the pre-therapeutic molecules and a pre-mRNA which is uniquely expressed in the specific target cells. The in vivo trans-splicing reaction provides an active therapeutic RNA which is functional as RNA or encodes a protein to be expressed in the target cells. The expression product of the mRNA is a protein of therapeutic value to the cell or a toxin which causes killing of the specific cells.
Patent DK-1180893-T3 (DK)
Inventor: GAU TI-YING TROY
IPC: H04L29/08
Filed: 2000-08-16
Granted: 2007-01-29
Abstract: A modem providing PPPoE (PPP over Ethernet) connections between the modem and a plurality of PPPoE Access Concentrators (PPPoE AC). The modem comprises a processor implementing the PPPoE protocol, a local port coupled to a local network and a remote port coupled to an access network. The modem of this invention removes the requirement that the PPP protocol stack and the PPPoE protocol stack must reside on the same machine. <IMAGE>
Patent DK-1029619-T3 (DK)
Inventor: SCEMAMA PHILIPPE
IPC: B23B13/02
Filed: 2000-01-05
Granted: 2005-01-24
Abstract: The bar feeder consists of a loader with retaining members which hold a number of bars on an inclined chute (14), loading sliders (28), a centering member and an advancing mechanism. The retaining members are in the form of fingers (42) which are shaped and posiitoned so that they continue to hold a bar picked yup by the sliders as they move vertically upwards. This means that the bar remains in contact during loading with two supporting surfaces - one (42B) on the finger and the other on a slider, virtually until the bar reaches its final position on the axis of its alignment.
Patent DK-1165274-T3 (DK)
Inventor: JUNG PAUL
IPC: B22D17/14
Filed: 2000-02-21
Granted: 2003-03-24
Abstract: The invention relates to a method for vacuum diecasting and a diecasting mould ( 1 ), especially for diecasting components made of metal or the alloys thereof. The aim of the invention is to provide a better casting quality while simplifying the procedure of the method. To this end, the evacuation of the die cavity ( 5 ) and the filling with molten bath are carried out independently from one another.
Patent DK-1161449-T3 (DK)
Inventor: FINDEIS MARK A
IPC: C07K5/083
Filed: 2000-03-03
Granted: 2007-11-05
Abstract: Compounds that modulate natural β amyloid peptide aggregation are provided. The modulators of the invention comprise a peptide, preferably based on a β amyloid peptide, that is comprised entirely of D-amino acids. Preferably, the peptide comprises 3-5 D-amino acid residues and includes at least two D-amino acid residues independently selected from the group consisting of D-leucine, D-phenylalanine and D-valine. In a particularly preferred embodiment, the peptide is a retro-inverso isomer of a β amyloid peptide, preferably a retro-inverso isomer of Aβ17-21. In certain embodiments, the peptide is modified at the amino-terminus, the carboxy-terminus, or both. Preferred amino-terminal modifying groups alkyl groups. Preferred carboxy-terminal modifying groups include an amide group, an acetate group, an alkyl amide group, an aryl amide group or a hydroxy group. Pharmaceutical compositions comprising the compounds of the invention, and diagnostic and treatment methods for amyloidogenic diseases using the compounds of the invention, are also disclosed.
Patent DK-1246581-T3 (DK)
Inventor: FILSER FRANK
IPC: A61C13/34
Filed: 2000-11-22
Granted: 2006-02-13
Abstract: The invention relates to an automatic machine tool (10), for the production of base structures (68), for false teeth, in particular, for tooth crowns and/or tooth bridges of exact three-dimensional shape. Said base structures (68) may be fixed to prepared natural and/or artificial tooth stumps. The machine tool (10) comprises a machine frame (12, 14), or a body, a work piece carrier, with a rotation shaft (38), at least one digitisation unit (46), at least one machining unit (52) and an electronic arithmetic and control unit (50) for all drive lines. A carrier for the workpiece, a blank (42), and/or for the machining unit(s) (52), serves as displacement unit, with three translational axes in the x-, y- and z-directions. The digitisation of the preparation model (44) and the machining of the blank (41) are carried out on the same machine tool (10), at different times. The machining paths for the blank (42) are calculated from the measured and stored digitised data and a predetermined material-specific scaling factor, before the machining of the blank.
Patent DK-1285857-T3 (DK)
Inventor: PALOSI GABOR
IPC: B65D25/28
Filed: 2002-08-20
Granted: 2007-02-19
Abstract: The tool box has a rib (37) on the front edge of its lid (7). A second rib (31) on the handle (29) presses against this and prevents the lid from opening when the handle is in the carrying position.
Patent DK-1297851-T3 (DK)
Inventor: BRISTOW MICHAEL R
IPC: A61P9/04
Filed: 2002-09-27
Granted: 2005-05-30
Abstract: The present invention provides for methods of treating and preventing cardiac hypertrophy. Class II HDACs, which are known to participate in regulation of chromatin structure and gene expression, have been shown to have beneficial effects on cardiac hypertrophy. Surprisingly, the present invention demonstrates that HDAC inhibitors inhibit cardiac hypertrophy by inhibiting fetal cardiac gene expression and interfering with sarcomeric organization. <IMAGE>
Patent DK-1329394-T3 (DK)
Inventor: CASEBASSE STEFANO
IPC: A63H33/00
Filed: 2002-01-18
Granted: 2010-08-02
Abstract: The present invention relates to a toy container (1) for alimentary products, comprising an outer tub (2) and an inner tub (3) which is housed in said outer tub (2) and has the function of an actual container, and also comprising movable elements (12) mounted in an articulated manner on the outside of said outer tub (2) and relating to the toy function. Said toy container (1) advantageously allows the provision of movable elements (12), thus being extremely attractive for children, while ensuring a seal against the leakage of food or beverages. <IMAGE>
Patent DK-1399144-T3 (DK)
Inventor: PLATA-SALAMAN CARLOS R
IPC: A61P25/20
Filed: 2002-02-21
Granted: 2006-07-24
Abstract: This invention is directed to a method for preventing or treating anxiety disorders comprising administering to a subject in need thereof a therapeutically effective amount of a compound selected from the group consisting of Formula (I) and Formula (II): wherein phenyl is substituted at X with one to five halogen atoms selected from the group consisting of fluorine, chlorine, bromine and iodine; and, R1, R2, R3, R4, R5 and R6 are independently selected from the group consisting of hydrogen and C1-C4 alkyl; wherein C1-C4 alkyl is optionally substituted with phenyl (wherein phenyl is optionally substituted with substituents independently selected from the group consisting of halogen, C1-C4 alkyl, C1-C4 alkoxy, amino, nitro and cyano).
Patent DK-1382531-T3 (DK)
Inventor: SCHMETZER HELMUT
IPC: B65B13/18
Filed: 2003-07-03
Granted: 2006-08-14
Abstract: The machine for fitting a strap (5) longitudinally on a package comprises rollers (9) mounted on swiveling arms (8). These draw the strap off a reel (4) and clamping jaws (12) hold it in position.
Patent DK-1369369-T3 (DK)
Inventor: LANGSCH ROBERT
IPC: B41F13/02
Filed: 2003-06-03
Granted: 2006-05-15
Abstract: The device has a rotation body structure with alternating foot and head sections forming a corrugated surface to deform the printing path enclosing the rotation body structure in a corrugated manner transversely to a direction of motion. Fluid channels in the rotation body structure open on its surface. The rotation body structure has a fluid connection to carry pressure fluid to the channels and through them to the surface of the structure.  The device has a rotation body structure (6) with alternating foot (7) and head (8) sections along a rotation axis (D) forming a corrugated surface (9,10) to deform the printing path (W) that encloses the rotation body structure in a corrugated manner transversely to a direction of motion. Fluid channels (15) formed in the rotation body structure open on its surface and the rotation body structure has a fluid connection (13,14;11) connected to the channels to carry pressure fluid to the channels and through them to the surface of the rotation body structure. AN Independent claim is also included for the following:  (a)  a method of compensating fan-out in a printing machine.
Patent DK-1480529-T3 (DK)
Inventor: MALANDAIN MICHEL
IPC: A23G4/02
Filed: 2003-02-05
Granted: 2008-02-18
Abstract: Coloring dragees involves at least one step of spraying with a colored aqueous dispersion (A) containing at least one film-forming polymer (I), a plasticizer (II) and a dye (III).  Independent claims are also included for: (1) a composition (A') for coloring dragees, which comprises 40-93 wt.% water, 4-15 wt.% polymer (I') for food or pharmaceutical use, 3-15 wt.% sparingly water soluble plasticizer (II') having a hydrocarbon chain of at least 12C, 0.1-15 wt.% dyes (III) and optionally upto 15 wt.% fillers, additives, sweeteners and/or aromas for food or pharmaceutical use, and (2) a solid composition (A'') for coloring dragees, which comprises 25-75 wt. % (I'), 5-25 wt. % (II') and optionally upto 70 wt. % fillers, additives, sweeteners and/or aromas for food or pharmaceutical use.
Patent DK-1592535-T3 (DK)
Inventor: OELLERICH JOERN
IPC: B05D3/12
Filed: 2003-11-05
Granted: 2010-12-13
Abstract: Surfaces of the plastic are abraded by directing a jet of an abrasive material in a gas at them.  Dried, oil free gas is employed, The stream of gas and abrasive is applied by a low pressure jet, preferably from a pressure vessel, at not more than2.5bar. Application of the abrasive stream by a vortex jet nozzle avoids excess treatment of local areas. Treatment continues until a completely matt surface is achieved. Residual abrasive is removed from the surface by blowing away with dry, oil-free compressed air. Quality control of the surface is effected by measuring surface resistance and/or through optical control using a comparison probe. Treatment occurs in a climate controlled, draught-free atmosphere. Prior to transportation the treated surface is vacuum packaged. The jetting medium is not guided in a circle. Highest surface quality is achieved when the abrasive stream is not guided in a circular movement. An Independent claim is included for a semi-finished product, preferably of carbon fiber reinforced plastic whose surfaces are prepared by the claimed method.
Patent DK-1699301-T3 (DK)
Inventor: LANDAZURI THOMAS
IPC: A23L9/20
Filed: 2003-12-30
Granted: 2009-01-05
Abstract: The invention relates to a cream filler composition, which comprises: a lipid fraction composed of a vegetable oil having a SFI of 0 at room temperature, a saturated fat fraction representing between 0% and 5% w/w of the total lipid fraction and a partially hydrogenated fat fraction representing between 0% and 1% w/w of the total lipid fraction, a powder sweetener composition, and a wheat gluten fraction having an increase gliadin content compared to the natural gliadin content in wheat gluten. The invention relates further to a method for preparing such a cream filler composition and food compositions comprising such a cream filler composition.
Patent DK-1618873-T3 (DK)
Inventor: BIRO ESZTER JULIANNA DR
IPC: A61K9/16
Filed: 2004-07-14
Granted: 2007-10-08
Abstract: Granules (I) for controlled release of tamsulosin comprises tamsulosin and a carrier matrix (A), where (A) comprises (wt.%): an alginate (2-25); a macromolecular substance (30-70) (e.g. polyvinyl acetate phthalate, cellulose acetate phthalate, carrageenan, crosslinked chitosan, xanthan gum and/or polyvinyl acetate); and a hydrophobic substance (10-50) (e.g. glycerol behenate, wax and/or calcium stearate). Granules (I) for controlled release of tamsulosin comprises, tamsulosin and a carrier matrix (A), where (A) comprises (wt.%): an alginate (2-25); a macromolecular substance (30-70) (methacrylic acid/ethyl acrylate 1:1 copolymer, methacrylic acid/methyl methacrylate 1:1 or 1:2 copolymers, aminoalkyl methacrylate copolymer, vinyl acetate/crotonic acid copolymer, polyvinyl acetate phthalate, ethylene-vinyl acetate, cellulose acetate phthalate, hydroxypropylmethylcellulose, sodium carboxymethylcellulose, carrageenan, crosslinked chitosan, polyethylene-vinyl acetate, poly-L-lactic acid, xanthan gum and/or polyvinyl acetate); and a hydrophobic substance (10-50) (glycerol behenate, glyceryl monostearate, wax, mono-, di- and trisubstituted glycerides and/or calcium stearate). Independent claims are also included for: (1) a hard gelatin capsule comprising (I); and (2) a process for producing (I).
Patent DK-1482451-T3 (DK)
Inventor: SOLOMON LAWRENCE
IPC: G08G1/0967
Filed: 2002-03-07
Granted: 2010-11-15
Abstract: A GPS positioning transceiver (300) comprises a receiver (302) for communicating with satellites and providing location data identifying locations of motor vehicles to a wireless tariff transceiver (304) including a data input (306) and a location data transmitter (308), transmitting packets to the traffic control server including a transceiver identification code and its location. A receiver (310) receives data identifying the road tariff for display on an output (312). Independent claims are included for a method for influencing vehicular traffic and for a traffic control server.
Patent DK-1473369-T3 (DK)
Inventor: WEINER DAVID B
IPC: C12N15/33
Filed: 1994-01-26
Granted: 2009-03-09
Abstract: Methods of introducing genetic material into cells of an individual and compositions and kits for practicing the same are disclosed. The methods comprise the steps of contacting cells of an individual with a polynucleotide function enhancer and administering to the cells, a nucleic acid molecule that is free of retroviral particles. The nucleic acid molecule comprises a nucleotide sequence that encodes a protein that comprises at least one epitope that is identical or substantially similar to an epitope of a pathogen antigen or an antigen associated with a hyperproliferative or autoimmune disease, a protein otherwise missing from the individual due to a missing, non-functional or partially functioning gene, or a protein that produces a therapeutic effect on an individual. Methods of prophylactically and therapeutically immunizing an individual against HIV are disclosed. Pharmaceutical compositions and kits for practicing methods of the present invention are disclosed.